VNSN Financials Monday, July 14, 2014 12:29:13 PM

VNSN Financials Monday, July 14, 2014 12:29:13 PM
Vansen Pharma Inc.
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue - - -
Cost of Revenue - - -
Gross Profit - - -
Operating Expenses
Research and Development - - -
Sales, General and Admin. 30 18 26
Non-Recurring Items - - -
Other - - -
Operating Income (30) (18) (26)
Income From Continuing Operations
Add'l Income/Expense Items - - -
Earnings Before Interest and Tax (30) (18) (26)
Interest Expense 7 7 6
Earnings Before Tax (37) (25) (32)
Income Tax - - -
Minority Interest - - -
Equity Earnings Unconsolidated Subsidiary - - -
Net Income Cont. Operations (37) (25) (32)
Non Recurring Events
Discontinued Operations - - -
Extraordinary Items - - -
Effect of Accounting Changes - - -
Other Items - - -
Net Income (37) (25) (32)
Preferred Stock and Other Adjustments - - -
Net Income Applicable to Common Shareholders (37) (25) (32)